VAR2 PHARMACEUTICALS ApS: Financial statements 2023
CVR: 34621942
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VAR2 PHARMACEUTICALS ApS (CVR 34621942) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -22,299,600 and a net result of DKK -19,118,976 compared with DKK -6,805,156 the year before. Equity in the 2023 report amounted to DKK 48,266,396. The solvency ratio was 81.3%. The company had 6 employees in the financial year.
- Gross Profit
- DKK -22,299,600
- Profit/Loss
- DKK -19,118,976
- Equity
- DKK 48,266,396
- Total Assets
- DKK 59,344,667
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -22.3 mio. | -19.1 mio. | 48.3 mio. | 6 |
| 2022 | - | -6.4 mio. | -6.8 mio. | 67.4 mio. | 5 |
| 2021 | - | -4.4 mio. | -5.9 mio. | 37 mio. | 7 |
| 2020 | - | -3.4 mio. | -5.4 mio. | 42.9 mio. | 8 |
| 2019 | - | -4.7 mio. | -6.9 mio. | 48.3 mio. | 8 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
VAR2 PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK -6,358,279, and the net result was DKK -6,805,156.
About VAR2 PHARMACEUTICALS ApS
VAR2 PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by ONCOMAL ApS and Københavns Universitet. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -21,739,014 and a net result of DKK -19,726,508 compared with DKK -21,006,013 the year before. Equity in the 2025 report amounted to DKK 82,032,248.